These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2157997)

  • 1. Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites.
    Sapolsky RM; Armanini MP; Packan DR; Sutton SW; Plotsky PM
    Neuroendocrinology; 1990 Mar; 51(3):328-36. PubMed ID: 2157997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of hypophysial portal concentrations of adrenocorticotropin secretagogues after fornix transection.
    Sapolsky RM; Armanini MP; Sutton SW; Plotsky PM
    Endocrinology; 1989 Dec; 125(6):2881-7. PubMed ID: 2555130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback.
    Plotsky PM; Otto S; Sapolsky RM
    Endocrinology; 1986 Sep; 119(3):1126-30. PubMed ID: 3015567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein.
    Dayanithi G; Antoni FA
    Endocrinology; 1989 Jul; 125(1):308-13. PubMed ID: 2544406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively.
    Link H; Dayanithi G; Föhr KJ; Gratzl M
    Endocrinology; 1992 Apr; 130(4):2183-91. PubMed ID: 1312449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
    Calogero AE; Liapi C; Chrousos GP
    J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of early glucocorticoid feedback by corticotropin-releasing factor in vitro.
    Shipston MJ; Antoni FA
    Endocrinology; 1992 Apr; 130(4):2213-8. PubMed ID: 1312450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.
    Aguilera G; Wynn PC; Harwood JP; Hauger RL; Millan MA; Grewe C; Catt KJ
    Neuroendocrinology; 1986; 43(1):79-88. PubMed ID: 3012395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis.
    Jacobson L; Sapolsky R
    Endocr Rev; 1991 May; 12(2):118-34. PubMed ID: 2070776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of central oxytocin and arginine vasopressin on changes in gastric motor function induced by chronic stress.
    Bülbül M; Sinen O; Gemici B; İzgüt-Uysal VN
    Peptides; 2017 Jan; 87():1-11. PubMed ID: 27829122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotrophic hormone release.
    Gomez F; Chapleur M; Fernette B; Burlet C; Nicolas JP; Burlet A
    J Neurosci Res; 1997 Nov; 50(4):565-74. PubMed ID: 9404718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat.
    Bruhn TO; Sutton SW; Plotsky PM; Vale WW
    Endocrinology; 1986 Oct; 119(4):1558-63. PubMed ID: 3019636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.
    Sheward WJ; Fink G
    J Endocrinol; 1991 Apr; 129(1):91-8. PubMed ID: 2030334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm.
    Herman JP; Adams D; Prewitt C
    Neuroendocrinology; 1995 Feb; 61(2):180-90. PubMed ID: 7753337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.